Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | TGF-beta receptor type-1 [162-503] | ||
Ligand | BDBM451795 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Caliper Assay | ||
IC50 | 1300±n/a nM | ||
Citation | Arista, L; Babu, S; Bian, J; Cui, K; Dillon, MP; Lattmann, R; Li, J; Liao, L; Lizos, D; Ramos, R; Stiefl, NJ; Ullrich, T; Usselmann, P; Wang, X; Waykole, LM; Weiler, S; Zhang, Y; Zhou, Y; Zhu, T Aminopyridine derivatives and their use as selective ALK-2 inhibitors US Patent US10947218 Publication Date 3/16/2021 | ||
More Info.: | Get all data from this article, Assay Method | ||
TGF-beta receptor type-1 [162-503] | |||
Name: | TGF-beta receptor type-1 [162-503] | ||
Synonyms: | ALK5 | Activin receptor-like kinase 5 (ALK-5)(aa 162-503) | Activin receptor-like kinase 5 (ALK5)(162-503) | SKR4 | TGFBR1 | TGFR1_HUMAN | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 38872.23 | ||
Organism: | Homo sapiens (Human) | ||
Description: | aa 162-503 | ||
Residue: | 342 | ||
Sequence: |
| ||
BDBM451795 | |||
n/a | |||
Name | BDBM451795 | ||
Synonyms: | US10710980, Example 27 | US10947218, Example 27 | ||
Type | Small organic molecule | ||
Emp. Form. | C29H36F2N4O2 | ||
Mol. Mass. | 510.6185 | ||
SMILES | Nc1ncc(cc1C(=O)N[C@H]1CC[C@H](O)CC1)-c1ccc(cc1)[C@]12C[C@H]1CN(C2)C1CCC(F)(F)CC1 |r,wU:25.27,10.10,wD:23.25,13.14,(-4.21,6.43,;-2.88,5.66,;-1.54,6.43,;-.21,5.66,;-.21,4.12,;-1.54,3.35,;-2.88,4.12,;-4.21,3.35,;-5.54,4.12,;-4.21,1.81,;-5.7,1.42,;-6.1,-.07,;-7.58,-.47,;-8.67,.62,;-10.16,.22,;-8.27,2.11,;-6.79,2.5,;1.12,3.35,;1.12,1.81,;2.46,1.04,;3.79,1.81,;3.79,3.35,;2.46,4.12,;5.13,1.04,;5.29,2.58,;6.53,1.67,;7.56,.53,;6.79,-.81,;5.29,-.49,;7.42,-2.21,;6.51,-3.46,;7.14,-4.87,;8.67,-5.03,;9.3,-6.43,;10.16,-5.43,;9.58,-3.78,;8.95,-2.37,)| | ||
Structure |